Trust Company of Vermont’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.98M | Buy |
+28,800
| New | +$2.57M | 0.11% | 122 |
|
|
2025
Q4 | $2.46M | Sell |
30,939
-3,212
| -9% | -$253K | 0.1% | 127 |
|
|
2025
Q3 | $2.57M | Sell |
34,151
-6,671
| -16% | -$457K | 0.11% | 125 |
|
|
2025
Q2 | $2.82M | Sell |
40,822
-2,823
| -6% | -$185K | 0.13% | 119 |
|
|
2025
Q1 | $2.96M | Sell |
43,645
-19,847
| -31% | -$1.19M | 0.15% | 113 |
|
|
2024
Q4 | $2.85M | Sell |
63,492
-44,876
| -41% | -$2.52M | 0.14% | 116 |
|
|
2024
Q3 | $6.81M | Sell |
108,368
-24,703
| -19% | -$1.44M | 0.34% | 74 |
|
|
2024
Q2 | $7.86M | Sell |
133,071
-13,543
| -9% | -$847K | 0.43% | 62 |
|
|
2024
Q1 | $11.7M | Buy |
146,614
+1,327
| +0.9% | +$101K | 0.65% | 47 |
|
|
2023
Q4 | $11.5M | Sell |
145,287
-22,540
| -13% | -$1.6M | 0.77% | 42 |
|
|
2023
Q3 | $11.7M | Sell |
167,827
-10,189
| -6% | -$722K | 0.79% | 39 |
|
|
2023
Q2 | $12.3M | Sell |
178,016
-2,423
| -1% | -$172K | 0.8% | 36 |
|
|
2023
Q1 | $13.4M | Buy |
180,439
+6,843
| +4% | +$574K | 0.94% | 27 |
|
|
2022
Q4 | $16.2M | Buy |
173,596
+737
| +0.4% | +$71.1K | 1.19% | 22 |
|
|
2022
Q3 | $16.5M | Buy |
172,859
+3,756
| +2% | +$372K | 1.3% | 15 |
|
|
2022
Q2 | $15.7M | Sell |
169,103
-94
| -0.1% | -$9.17K | 1.2% | 18 |
|
|
2022
Q1 | $17.1M | Sell |
169,197
-441
| -0.3% | -$46.3K | 1.16% | 20 |
|
|
2021
Q4 | $17.5M | Buy |
169,638
+1,852
| +1% | +$171K | 1.1% | 23 |
|
|
2021
Q3 | $14.2M | Buy |
167,786
+6,841
| +4% | +$573K | 1.01% | 26 |
|
|
2021
Q2 | $13.4M | Buy |
160,945
+8,943
| +6% | +$732K | 0.94% | 29 |
|
|
2021
Q1 | $11.4M | Buy |
152,002
+10,569
| +7% | +$770K | 0.86% | 37 |
|
|
2020
Q4 | $9.66M | Buy |
141,433
+16,812
| +13% | +$1.09M | 0.77% | 41 |
|
|
2020
Q3 | $7.28M | Buy |
124,621
+9,899
| +9% | +$616K | 0.67% | 48 |
|
|
2020
Q2 | $7.45M | Sell |
114,722
-31,878
| -22% | -$2.01M | 0.74% | 43 |
|
|
2020
Q1 | $8.7M | Buy |
146,600
+21,011
| +17% | +$1.4M | 0.81% | 41 |
|
|
2019
Q4 | $9.33M | Buy |
125,589
+9,159
| +8% | +$643K | 0.7% | 50 |
|
|
2019
Q3 | $7.34M | Buy |
116,430
+24,592
| +27% | +$1.46M | 0.59% | 59 |
|
|
2019
Q2 | $5M | Buy |
91,838
+29,686
| +48% | +$1.6M | 0.42% | 75 |
|
|
2019
Q1 | $3.35M | Buy |
62,152
+15,250
| +33% | +$941K | 0.29% | 88 |
|
|
2018
Q4 | $3.07M | Buy |
46,902
+9,219
| +24% | +$688K | 0.3% | 88 |
|
|
2018
Q3 | $2.97M | Buy |
37,683
+11,497
| +44% | +$822K | 0.25% | 98 |
|
|
2018
Q2 | $1.69M | Buy |
26,186
+776
| +3% | +$51.1K | 0.15% | 136 |
|
|
2018
Q1 | $1.58M | Sell |
25,410
-3,575
| -12% | -$257K | 0.15% | 134 |
|
|
2017
Q4 | $2.1M | Sell |
28,985
-601
| -2% | -$43.7K | 0.2% | 117 |
|
|
2017
Q3 | $2.4M | Sell |
29,586
-211
| -0.7% | -$16.7K | 0.24% | 109 |
|
|
2017
Q2 | $2.4M | Sell |
29,797
-1,536
| -5% | -$121K | 0.25% | 109 |
|
|
2017
Q1 | $2.46M | Sell |
31,333
-1,796
| -5% | -$143K | 0.27% | 105 |
|
|
2016
Q4 | $2.62M | Sell |
33,129
-6,947
| -17% | -$562K | 0.3% | 97 |
|
|
2016
Q3 | $3.57M | Buy |
40,076
+1,298
| +3% | +$123K | 0.45% | 73 |
|
|
2016
Q2 | $3.71M | Buy |
38,778
+2,302
| +6% | +$229K | 0.49% | 72 |
|
|
2016
Q1 | $3.78M | Buy |
36,476
+3,387
| +10% | +$329K | 0.53% | 65 |
|
|
2015
Q4 | $3.23M | Buy |
33,089
+2,502
| +8% | +$245K | 0.46% | 72 |
|
|
2015
Q3 | $2.95M | Buy |
30,587
+3,180
| +12% | +$334K | 0.46% | 72 |
|
|
2015
Q2 | $2.87M | Buy |
27,407
+294
| +1% | +$30K | 0.42% | 77 |
|
|
2015
Q1 | $2.8M | Sell |
27,113
-286
| -1% | -$28.9K | 0.41% | 77 |
|
|
2014
Q4 | $2.64M | Buy |
27,399
+273
| +1% | +$24.1K | 0.38% | 79 |
|
|
2014
Q3 | $2.16M | Sell |
27,126
-294
| -1% | -$23.2K | 0.33% | 92 |
|
|
2014
Q2 | $2.07M | Sell |
27,420
-672
| -2% | -$50.8K | 0.32% | 91 |
|
|
2014
Q1 | $2.1M | Buy |
28,092
+383
| +1% | +$27.1K | 0.34% | 83 |
|
|
2013
Q4 | $1.98M | Sell |
27,709
-564
| -2% | -$36.2K | 0.33% | 89 |
|
|
2013
Q3 | $1.6M | Sell |
28,273
-456
| -2% | -$27.2K | 0.29% | 96 |
|
|
2013
Q2 | $1.64M | Buy |
+28,729
| New | +$1.66M | 0.32% | 93 |
|
Other funds holding CVS
Trust Company of Vermont's CVS Position: Q2 2026 in Review
Trust Company of Vermont opened a new position in CVS Health (CVS) in Q2 2026: 28,800 shares worth $2.98M. The stake represents 0.11% of the portfolio and ranks #122 among its holdings. This is a return to the name: Trust Company of Vermont previously reported a position in CVS as recently as Q4 2025.
Trust Company of Vermont first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.5M in Q4 2021. 1,242 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Trust Company of Vermont held 28,800 shares of CVS Health worth $2.98M as of Q2 2026.
- CVS Health was a new Trust Company of Vermont position in Q2 2026.
- CVS Health made up 0.11% of Trust Company of Vermont's portfolio in Q2 2026, its #122 holding.
- Trust Company of Vermont first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Trust Company of Vermont's CVS Health position peaked at $17.5M in Q4 2021.
- 1,242 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Trust Company of Vermont's 13F filing for Q2 2026, filed 7 Aug 2026.